Ramius Capital Group

Active

Updated: Apr 2, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Mar 1, 2025	Latigo Biotherapeutics	$150.0M Series B	Ramius Capital Group	5AM Ventures, Foresite Capital, Westlake Village BioPartners
Jul 1, 2012	Bluebird Bio	$60.0M Series D	—	ARCH Venture Partners, Third Rock Ventures, Howie Furst, Forbion, RA Capital Management, Shire, TVM Capital